FY2021
Restart groundwork
The October 2020 scoping study led into technical work on sorting, power, acid recovery and tailings while Kayelekera remained on care and maintenance.
ASX: LOT · Five-year financial review
(ASX: LOT) Lotus Resources Limited Financial Review - FY2021~25
Lotus Resources moved from maintaining an idle uranium mine to funding Kayelekera’s restart. The five-year record combines repeated equity raising, a major Botswana acquisition and a step-up in construction cash use. Accounting losses, restricted environmental funding and future uranium deliveries each tell a different part of that story.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
FY2025 cash
A$54.092m
Excludes restricted environmental bond.
FY2025 equity proceeds
A$132.266m
Gross cash proceeds, before issue costs.
FY2025 plant cash spend
A$57.822m
Equipment purchases in investing cash flow.
FY2025 Group loss
A$15.584m
Includes non-controlling interests.
Five years in context
The early years focused on restart studies and care and maintenance. Lotus increased its Kayelekera interest during FY2022, then completed the restart DFS and settled the remaining vendor obligations during FY2023.
A-Cap added Letlhakane in FY2024; FY2025 shifted the spending profile toward Kayelekera construction. The accounts still precede first post-year-end production and expected revenue receipts, so planned output is not presented as historical sales.
Events behind the numbers
FY2022
Larger Kayelekera interest
Following July 2021 approval, share consideration increased the economic interest from 65% to 85%. The Hylea tenement disposal generated a separate gain rather than mine revenue.
FY2023
DFS, placement and final vendor settlement
The restart DFS was released in August 2022 and a September placement funded development and the final March 2023 environmental-bond repayment.
FY2024
Letlhakane joins; Wilconi exits
A-Cap closed in November 2023. The enlarged Group retained the uranium projects but withdrew from Wilconi, fully impairing its nickel-cobalt asset.
FY2025
Accelerated restart funded
A large equity raising supported the accelerated Kayelekera restart. A fiscal-stability agreement and power-supply arrangements accompanied construction; first production came after June year-end.
FINANCIAL REVIEW / 01
A smaller loss did not mean a smaller construction programme
The FY2024 loss included the Wilconi write-off. With much lower impairment in FY2025, the Group loss narrowed even as restart capital spending accelerated. That is why loss and investing cash flow should not be treated as interchangeable measures.
Care and maintenance remained a recurring cost; corporate and share-based expenses grew in the latest year. Earlier other gains included the Hylea disposal. Neither that gain nor interest income is evidence of uranium production revenue.
Group loss and recurring care costs
A$ million
Group loss after taxCare and maintenance expense
AI-generated presentation · values from Group earnings and the costs behind the loss; no missing values plotted as zero.
Group earnings and the costs behind the loss
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Group loss after tax | (5.898) | (12.963) | (10.561) | (25.244) | (15.584) |
| Loss attributable to owners | (5.014) | (11.996) | (9.917) | (24.507) | (13.760) |
| Other income / gains, net | 0.188 | 2.580 | 1.196 | 1.670 | 3.572 |
| Corporate and administrative expense | (2.310) | (2.680) | (2.888) | (3.609) | (6.792) |
| Care and maintenance expense | (3.371) | (3.543) | (3.573) | (3.742) | (5.779) |
| Exploration and evaluation expense | 0.000 | (4.696) | (1.064) | (3.062) | (0.721) |
| Share-based payment expense | (0.404) | (3.243) | (1.917) | (3.162) | (4.615) |
| Depreciation — separately presented line | (0.001) | (0.001) | (0.002) | (0.003) | (0.477) |
A$ million; negative amounts are losses/expenses. Group loss includes non-controlling interests and is not identical to the owners’ loss. Other income includes investment/disposal income, not uranium sales.
FY2021 uses the FY2022 reclassified cost presentation: E&E is expressly nil and share-based payments/depreciation are separately shown. FY2022 corporate expense uses the FY2023 comparative, which separately presents finance costs. These are classification changes, not changes in total loss.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Finance, impairment and tax lines
A$ million
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Finance costs — rehabilitation accretion | (1.429) | (1.310) | 0.000 |
| Finance costs — other | (0.149) | (0.132) | 0.000 |
| Plant and equipment impairment | (0.523) | (1.424) | (0.064) |
| Income tax expense | (0.211) | (0.023) | (0.119) |
Accretion of rehabilitation provisions is not a cash loan drawdown. The FY2022 statement additionally reports A$1.243m impairment; its later comparative separately classifies A$0.138m other finance cost.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Exploration impairment after the A-Cap acquisition
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Separately reported E&E impairment | (10.447) | (0.036) |
FY2024 is the Wilconi write-off following withdrawal from the nickel-cobalt joint venture. It is not a second FY2025 charge. The exploration-asset note’s provision movement also includes exploration already charged to earnings; do not count it twice.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 02
New capital funded the step from studies to restart
Equity raisings were the main replenishment of cash. FY2025 investing outflow includes short-term investment purchases as well as plant and exploration payments, so it should not all be labelled project capex.
At year-end, term deposits could have maturities of up to six months. Longer-dated deposits therefore moved outside cash equivalents even though they remained financial assets; exchange-rate movements also affected the translated closing cash balance.
Operating, investing and financing cash flows
A$ million
Net operating cash flowNet investing cash flowNet financing cash flow
AI-generated presentation · values from Funding versus cash deployment; no missing values plotted as zero.
Gross equity cash and issue costs
A$ million
Gross share-issue proceedsShare-issue costs paid
AI-generated presentation · values from Funding versus cash deployment; no missing values plotted as zero.
Funding versus cash deployment
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net operating cash flow | (6.506) | (9.963) | (8.343) | (7.328) | (10.317) |
| Net investing cash flow | (1.318) | (1.603) | (5.043) | (2.648) | (85.283) |
| Net financing cash flow | 20.897 | 1.073 | 24.136 | 28.722 | 125.051 |
| Gross share-issue proceeds | 17.404 | 0.174 | 25.000 | 30.000 | 132.266 |
| Share-issue costs paid | (1.302) | 0.000 | (1.346) | (1.828) | (7.215) |
| Option-exercise proceeds | 4.823 | 0.899 | 0.482 | 0.550 | 0.000 |
Signed statutory cash-flow measures. FY2022 share-issue costs and FY2025 option proceeds are expressly nil. Acquisition securities are not cash proceeds.
FY2025 exchange-rate movements reduced the translated cash balance by A$9.485m, separately from the net cash-flow increase. Financing inflow is not operating revenue.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FY2025 cash use during the accelerated restart
A$ million
| Metric | FY2025 |
|---|---|
| Operating: suppliers and employees | (7.017) |
| Operating: care, maintenance and exploration | (5.976) |
| Operating: pre-production costs | (0.552) |
| Investing: exploration payments | (5.575) |
| Investing: plant and equipment purchases | (57.822) |
| Investing: short-term investment purchases | (21.842) |
Selected components, not an additional subtotal. Short-term deposits are financial investments, not mine capex; deposits with original maturity exceeding three months sit outside cash equivalents.
Cash plant purchases are not equal to A$42.354m accounting PPE additions or A$41.953m closing PPE. The issuer describes separate project-related prepayments for equipment, refurbishment and services.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 03
Liquidity, restricted funds and project assets are different
The FY2021 cash figure is shown on the later restated basis, excluding the environmental performance bond. Keeping restricted collateral separate prevents a reclassification being mistaken for cash consumption.
The bond provides environmental security; the rehabilitation provision estimates the wider future closure obligation. Paying the remaining Paladin instalments in March 2023 did not release the bond for general operations or extinguish that closure obligation.
The FY2024 asset increase was mainly acquisition-driven. A-Cap was an asset acquisition, not an operating earnings contribution at a comparable scale; its securities consideration should not be read as a cash purchase or organically generated equity.
Cash versus restricted environmental collateral
A$ million
Cash and cash equivalents — excludes restricted bondRestricted environmental performance bond
AI-generated presentation · values from Cash, project assets and obligations at 30 June; no missing values plotted as zero.
Exploration and plant carrying values
A$ million
Exploration and evaluation carrying valuePlant and equipment carrying value
AI-generated presentation · values from Cash, project assets and obligations at 30 June; no missing values plotted as zero.
Cash, project assets and obligations at 30 June
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents — excludes restricted bond | 14.752 | 4.876 | 15.519 | 34.126 | 54.092 |
| Exploration and evaluation carrying value | 59.798 | 46.279 | 39.532 | 118.178 | 124.039 |
| Plant and equipment carrying value | 0.001 | 0.004 | 0.004 | 0.164 | 41.953 |
| Total Group liabilities | 66.519 | 51.833 | 38.086 | 41.426 | 43.907 |
| Restricted environmental performance bond | 13.573 | 14.553 | 15.053 | 15.000 | 15.310 |
| Mine closure / rehabilitation provision | 56.202 | 42.729 | 37.258 | 38.168 | 38.915 |
FY2021 cash uses the explicit FY2022 restatement, removing the environmental bond from cash equivalents. The bond remains a separate restricted asset, not freely available cash.
Rehabilitation provision is a liability estimate, not the same as bond collateral or the final vendor instalments paid in March 2023. FY2025 E&E, bond and rehabilitation balances are directly disclosed in saved narrative claims.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Complete Group balance-sheet totals available through FY2024
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Total assets | 88.863 | 66.607 | 71.771 | 168.821 |
| Total equity / net assets | 22.344 | 14.774 | 33.685 | 127.395 |
The saved FY2025 extraction does not retain complete Group asset/equity totals. The latest supported components above are not summed into an incomplete total, and parent-only totals are not substituted.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FY2024 exploration-asset movements
A$ million
| Metric | FY2024 |
|---|---|
| Opening E&E carrying value | 39.532 |
| A-Cap exploration assets acquired | 88.608 |
| Exploration and evaluation expenditures | 5.303 |
| Provision / write-down movement | (13.509) |
| Change in rehabilitation estimate | (0.247) |
| Exchange-rate movement | (1.508) |
These movements reconcile to the A$118.178m closing balance above. The A$13.509m write-down movement includes A$3.062m exploration expense and A$10.447m Wilconi impairment already recognised in P&L.
A-Cap’s total acquisition consideration / acquired net assets was A$89.519m, predominantly securities rather than a cash purchase. E&E assets acquired were A$88.608m, not total consideration.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 04
Contracts create obligations, not recognised sales
Four binding uranium offtakes cover deliveries in 2026–2029. The report also describes borrowing facilities and equipment financing, but contractual facility sizes are not substituted for drawn debt in these historical accounts.
Restart-related expenditure commitments and revenue-linked royalties matter to the next phase. These are disclosed obligations and terms, not a valuation: the latest report describes A$7.588m of near-term expenditure commitments, government/vendor royalties and a community-development revenue contribution.
First production and the subsequent placement were after 30 June 2025. They explain the next chapter but are not included in FY2025 sales or closing cash.
Reading the figures
- FY2021 cash is the explicitly restated comparative; FY2021–FY2022 cost categories use identified later reclassifications without changing Group loss.
- FY2025 Group total assets/equity are not retained in the selected extraction. Supported cash, liabilities, E&E, PPE, collateral and provision balances are shown without inventing a complete total.
- Wilconi’s large impairment and A-Cap’s eight-month initial consolidation belong to FY2024. Conflicting later narrative dating is not used to duplicate the charge.
- Saved claims differ on the exact first-production date, but agree that it was after June 2025; this review makes no more precise date claim.
- Prepared from existing year-by-year extraction records only. No raw-source retrieval, database query, financial web research or MiniMax call. GPT review against saved extractions; not an independent original-document audit.
Annual-report source registry
- Lotus Resources Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
- Lotus Resources Limited - Annual report for year ended 30 June 2022Existing annual extraction, including separately identified historical comparatives.
- Lotus Resources Limited - Annual Report & Statutory AccountsExisting annual extraction, including separately identified historical comparatives.
- Lotus Resources Limited - Annual Report & Statutory AccountsExisting annual extraction, including separately identified historical comparatives.
- Lotus Resources Limited - 2025 Annual Report to ShareholdersExisting annual extraction, including separately identified historical comparatives.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
Sources, copyright and independence
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
AI-led method
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
Information notice
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.